European Chemical Agency (ECHA) and Health and Safety Executive (HSE) Update: June 2025

Regulatory Management

Chemical

Defence Status

Harmonised Classification and Labelling: New Intentions

N/A

N/A

Harmonised Classification and Labelling: Dossier Submitted

Acetyl Hexamethyl Tetralin (AHTN), Annex III entry 182, CMR 1B (repr) (legal deadline for opinion adoption 30.07.26)

Interest in defence TBC

Hexamethylindanopyran (Galaxolide), Annex III entry 336, CMR 1B (repr) (legal deadline for opinion adoption 12.06.26)

Interest in defence TBC

Aminomethyl propanol, Annex III entry 61, CMR 1B (repr) (legal deadline for opinion adoption 28.05.26)

Interest in defence TBC

Cannabidiol, no entry in CPR Annexes, CMR 1B (repr) (legal deadline for opinion adoption 20.08.26)

No interest in defence, no Cosmetics Europe led dossier

Sodium bromate, no entry in CPR Annexes, CMR 1B, 2 (legal deadline for opinion adoption 01.08.26)

No interest in defence

Hydroxycitronellal, Annex III entry 72, CMR 2 (submitted for accordance check 20.12.24)

IFRA to lead defence

Committee for Risk Assessment (RAC) Opinion Published

AcetophenoneNo entry in CPRCMR 1B (repr)

No interest in defence

p-CymeneNo entry in CPRCMR 1B (repr) (opinion adopted 28.11.24, not available online yet)

Cosmetics Europe defence consortium

HeliotropineNo entry in CPRCMR 1B (repr) (opinion adopted 17.09.24)

Cosmetics Europe defence consortium

REACH Restrictions

N/A

N/A

SVHC Classification and Authorisation

Linear siloxane hexamethyldisiloxane (L2), no entry in CPR Annexes, SVHC proposal (PBT) (withdrawn)

N/A

Octamethyltrisiloxane (L3), no entry in CPR Annexes, SVHC proposal (vPvB)(included in Candidate List 21.01.25)

N/A

Linear siloxane decamethyltetrasiloxane (L4), no entry in CPR Annexes, SVHC proposal (vPvB) (consultation ended 14.04.25)

N/A

Linear siloxane dodecamethylpentasiloxane (L5), no entry in CPR Annexes, SVHC proposal (vPvB) (expected submission 02.02.26)

N/A

Regulatory Management

Chemical

Defence Status

Mandatory Classification and Labelling

Heliotropine

CMR 1B (reprotox)

Technical report published

CTPA will liaise with Cosmetics Europe on the defence dossier

Silver, mass

CMR 2 (reprotox)

Final opinion published

Defence not led by CTPA, status unknown

Pentetic acid

CMR 1B (reprotox)

Technical report published

No interest in defence

REACH Restrictions

Microplastics

Evidence project report

N/A

SVHC Classification and Authorisation

N/A

N/A